Your browser doesn't support javascript.
loading
Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma: case report.
Maruyama, Michihiro; Asano, Takehide; Kenmochi, Takashi; Kainuma, Osamu; Iwasaki, Kotaro; Miyauchi, Hideaki; Saigo, Kenichi; Miura, Fumihiko; Kobayashi, Susumu; Ochiai, Takenori.
Afiliación
  • Maruyama M; Second Department of Surgery, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-0877 Japan.
Anticancer Res ; 23(3C): 2987-9, 2003.
Article en En | MEDLINE | ID: mdl-12926150
ABSTRACT

BACKGROUND:

Radiofrequency ablation (RFA) is one of the standard percutaneous therapies for hepatocellular carcinoma (HCC), but RFA has not been applied to treat bone metastasis from HCC. CASE A 65-year-old male patient, who underwent hepatectomy for HCC two and a half years previously, complained of pain in his right thigh. Imaging modalities and a needle biopsy revealed metastatic HCC in his right acetabulum. The first RFA therapy was attempted under computed tomography (CT) guidance with 42 Gy radiation therapy. The second RFA therapy was performed for tumor recurrence in his pelvis at 4 years after the first RFA.

CONCLUSION:

RFA is a safe, easy, repeatable and effective therapy and should be one of the most important therapeutic modalities for bone metastasis from HCC.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Ablación por Catéter / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Guideline Límite: Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Año: 2003 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Ablación por Catéter / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Guideline Límite: Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Año: 2003 Tipo del documento: Article